Examkin

Patient Management

2074 questions

All types2,074Multiple choice1,048Multiple select393Matching221Ordering412
Question 1121Question →

A 68-year-old woman is brought to the emergency department by emergency medical services for severe, sudden-onset shortness of breath that began 45 minutes ago. She has a medical history of hypertension, type 2 diabetes mellitus, and coronary artery disease. Upon arrival, the patient is visibly distressed, diaphoretic, and using accessory muscles of respiration. She is unable to speak in full sentences. Vital signs are temperature 37.0°C (98.6°F), blood pressure 215/115 mmHg, heart rate 118/min, respiratory rate 34/min, and oxygen saturation 81% on room air. Physical examination reveals elevated jugular venous pressure and diffuse bilateral crackles extending to the mid-lung fields. She is expectorating pink, frothy sputum. Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Initiate noninvasive positive pressure ventilation

Answer

The most appropriate initial step is to initiate noninvasive positive pressure ventilation to immediately stabilize the patient's respiratory status.
The correct response addresses the patient's acute hypoxic respiratory failure and severe work of breathing. This presentation is highly characteristic of acute decompensated heart failure (ADHF) with flash pulmonary edema, driven by a hypertensive emergency. In the acute setting, the primary goal of stabilization follows the ABCs (Airway, Breathing, Circulation). Noninvasive positive pressure ventilation (NIPPV), such as continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP), is the cornerstone of immediate management for ADHF. It improves oxygenation, decreases the work of breathing, and provides positive intrathoracic pressure, which favorably reduces both preload and afterload. This critical therapeutic intervention must precede any diagnostic testing.

Step-by-Step Solution

1
Identify the primary pathophysiological process based on the clinical presentation.
The patient's acute severe dyspnea, extreme hypertension, severe hypoxia, and pink frothy sputum indicate acute decompensated heart failure presenting as flash pulmonary edema.
Accurate syndrome recognition is essential to direct the appropriate stabilization pathway.
2
Evaluate the patient's hemodynamic and respiratory stability.
The patient is in impending respiratory failure (SpO2 81%, RR 34/min, accessory muscle use) requiring immediate resuscitation.
According to the principles of initial stabilization and triage (ABCs), airway and breathing must be secured before any definitive diagnostic workup.
3
Determine the most appropriate immediate intervention.
Noninvasive positive pressure ventilation (NIPPV) is selected as the priority.
NIPPV provides rapid respiratory support, improves oxygenation, and reduces both cardiac preload and afterload, which is critical in hypertensive flash pulmonary edema.

Key Concept

In patients presenting with severe respiratory distress and hypoxia due to acute decompensated heart failure, immediate stabilization with noninvasive positive pressure ventilation (NIPPV) must be prioritized over diagnostic testing or disposition.
Question 1122Question →

A 62-year-old female is evaluated in the inpatient dermatology consultation service for exquisitely painful, violaceous, and necrotic skin lesions on her bilateral thighs and lower abdomen that have rapidly progressed over the past two weeks. She has a history of end-stage renal disease secondary to diabetic nephropathy and receives hemodialysis three times weekly. She also has a history of permanent atrial fibrillation and diet-controlled type 2 diabetes mellitus. Her current medications include calcium acetate, calcitriol, warfarin, and metoprolol succinate. Vital signs are within normal limits. Physical examination reveals retiform purpura with central areas of black eschar and surrounding indurated erythema on the proximal lower extremities and adiposity-rich areas of the abdomen. The lesions are extremely tender to palpation. Peripheral pulses are intact. Laboratory evaluation shows:

Serum calcium: 10.2 mg/dL10.2 \text{ mg/dL}
Serum phosphorus: 7.8 mg/dL7.8 \text{ mg/dL}
Intact parathyroid hormone (PTH): 850 pg/mL850 \text{ pg/mL}
International Normalized Ratio (INR): 2.42.4

A punch biopsy of the lesion margin demonstrates microvascular calcification, extensive intimal fibroplasia, and cutaneous ischemia without evidence of systemic vasculitis. Which of the following sets of pharmacologic interventions is most appropriate for the management of this patient's dermatologic condition?

Show answer & explanation

Answer: Initiate intravenous sodium thiosulfate, substitute calcium acetate with sevelamer, and transition warfarin to apixaban

Answer

The most appropriate management is to initiate intravenous sodium thiosulfate, substitute calcium acetate with sevelamer, and transition warfarin to apixaban.
The correct combination directly addresses the three pillars of calciphylaxis management in this patient: active treatment, calcium-phosphorus product reduction, and removal of iatrogenic triggers. Intravenous sodium thiosulfate acts as a calcium chelator and antioxidant to promote lesion healing. Calcium acetate must be stopped because it contributes to an unacceptably high calcium-phosphorus product (>55 mg2/dL2> 55 \text{ mg}^2\text{/dL}^2 is high risk); it should be replaced with a non-calcium, non-aluminum binder like sevelamer. Finally, warfarin is a notorious trigger for calciphylaxis because it inhibits the vitamin K-dependent activation of Matrix Gla Protein, a critical defense against vascular calcification. Since the patient requires ongoing anticoagulation for atrial fibrillation, switching to apixaban is appropriate, as it does not inhibit MGP and has an established safety profile in hemodialysis patients.

Step-by-Step Solution

1
Diagnose the primary dermatologic condition based on clinical and biopsy findings.
The patient has calciphylaxis (calcific uremic arteriolopathy).
The presentation of exquisitely painful retiform purpura with necrotic eschars in an end-stage renal disease (ESRD) patient, combined with a high calcium-phosphorus product (10.2×7.8=79.56 mg2/dL210.2 \times 7.8 = 79.56 \text{ mg}^2\text{/dL}^2) and biopsy showing microvascular calcification without vasculitis, is pathognomonic.
2
Identify current medications that are exacerbating the condition.
Calcium acetate, calcitriol, and warfarin must be discontinued.
Calcium acetate and calcitriol actively increase the serum calcium and phosphorus burden. Warfarin acts as a direct molecular trigger for calciphylaxis by inhibiting the vitamin K-dependent carboxylation of Matrix Gla Protein (MGP), an essential endogenous inhibitor of tissue calcification.
3
Select the appropriate pharmacologic substitutions and targeted therapies.
Use sodium thiosulfate, sevelamer, and apixaban.
Intravenous sodium thiosulfate is a potent antioxidant and vasodilator that increases the solubility of calcium deposits. Sevelamer provides necessary phosphate binding without adding a calcium load. Apixaban provides required systemic anticoagulation for atrial fibrillation with established safety and FDA approval for patients on hemodialysis, unlike dabigatran, rivaroxaban, or enoxaparin.

Key Concept

Successful management of calciphylaxis in ESRD requires initiating intravenous sodium thiosulfate, aggressively lowering the calcium-phosphorus product (avoiding calcium-based binders and active vitamin D), and discontinuing warfarin, which actively promotes vascular calcification via inhibition of Matrix Gla Protein.
Question 1123Question →

A 58-year-old man presents to the emergency department with a 3-day history of progressively worsening mid-back pain and subjective fevers. Over the past 12 hours, he has noted profound weakness in both legs and an inability to urinate. His medical history is significant for type 2 diabetes mellitus and opioid use disorder, with his last intravenous injection occurring one week ago. His temperature is 38.6°C (101.5°F), blood pressure is 110/70 mmHg, pulse is 108/min, and respiratory rate is 18/min. Physical examination reveals focal tenderness to percussion over the midthoracic spine. Neurologic examination demonstrates 3/5 motor strength in the bilateral lower extremities, decreased pinprick sensation below the umbilicus, and absent patellar and Achilles reflexes. Digital rectal examination reveals markedly diminished anal sphincter tone. Which of the following diagnostic tests are indicated as the most appropriate next steps in this patient's evaluation? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Magnetic resonance imaging of the entire spine with and without contrast; Peripheral blood cultures

Answer

The most appropriate immediate diagnostic steps are magnetic resonance imaging of the entire spine with and without contrast, and peripheral blood cultures.
This patient's presentation of fever, focal back pain, and acute myelopathy in the setting of intravenous drug use is highly suspicious for a spinal epidural abscess (SEA) causing acute spinal cord compression. The diagnostic workup must rapidly confirm the presence and extent of the abscess and identify the causative pathogen simultaneously. Magnetic resonance imaging of the entire spine with and without gadolinium contrast is the gold-standard imaging modality. The entire spine is evaluated because synchronous, non-contiguous skip lesions are common. Concurrently, peripheral blood cultures should be obtained before initiating empiric antimicrobial therapy, as they are frequently positive and can often obviate the need for invasive epidural tissue sampling.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
The patient exhibits the classic triad of spinal epidural abscess (SEA): severe back pain, fever, and acute neurologic deficits (paraparesis, sensory level, urinary retention, and diminished rectal tone). The risk is elevated by his history of intravenous drug use and diabetes.
Recognizing the syndrome of acute spinal cord compression secondary to infection dictates the urgency and type of the diagnostic workup.
2
Determine the optimal imaging strategy.
Urgent magnetic resonance imaging (MRI) of the entire spine with and without gadolinium contrast is indicated.
MRI provides the necessary soft-tissue resolution to identify an epidural abscess and assess cord compression. The entire spine must be imaged because non-contiguous 'skip' lesions occur in nearly 10% of cases.
3
Determine the appropriate microbiologic diagnostic sequencing.
Peripheral blood cultures must be drawn concurrently with the arrangement for imaging.
Blood cultures will identify the causative organism (most commonly Staphylococcus aureus) in over 60% of cases. They must be obtained prior to the administration of empiric broad-spectrum antibiotics to guide definitive therapy.

Key Concept

Diagnostic Workup and Test Sequencing for suspected spinal epidural abscess requires immediate, concurrent execution of non-invasive definitive imaging (whole-spine MRI) and microbiologic sampling (blood cultures), while strictly avoiding contraindicated procedures like lumbar puncture.
Question 1124Question →

A 45-year-old man with a history of traumatic brain injury and alcohol use disorder is brought to the emergency department by emergency medical services due to a continuous seizure. Paramedics report the patient has had uninterrupted generalized tonic-clonic movements for the past 18 minutes. He is unresponsive and exhibits continuous rhythmic motor activity of all four extremities. His blood pressure is 152/94 mmHg, heart rate is 128/min, and oxygen saturation is 95% on a non-rebreather mask. Two large-bore peripheral intravenous lines are successfully established.

Arrange the following pharmacologic interventions in the correct protocolized sequence for escalating the management of status epilepticus, starting with the initial first-line therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for escalating the management of status epilepticus is: 1) Intravenous lorazepam, 2) Intravenous fosphenytoin, 3) Intravenous propofol infusion, 4) Intravenous pentobarbital coma.
Status epilepticus is a neurologic emergency requiring a strict, time-dependent algorithmic approach to pharmacologic management. The sequence is defined by phases based on seizure duration and response to prior medications.

1. Initial Therapy (First-line): Intravenous lorazepam (or diazepam/midazolam) is the immediate treatment of choice. Benzodiazepines rapidly enhance GABA_A receptor activity to terminate the seizure.

2. Urgent Control Therapy (Second-line): Intravenous fosphenytoin (or valproate/levetiracetam) is administered to achieve sustained seizure control and prevent recurrence, especially if benzodiazepines fail to halt the seizure. Fosphenytoin blocks voltage-gated sodium channels.

3. Refractory Therapy (Third-line): If seizures persist despite first- and second-line agents (refractory status epilepticus), patients require intubation and continuous intravenous anesthetic infusions, such as propofol or midazolam, to suppress cortical electrical activity.

4. Super-Refractory Therapy (Fourth-line): For seizures that persist despite 24 hours of anesthetic infusions, induction of a barbiturate coma (e.g., intravenous pentobarbital) is the final escalation step to achieve profound burst suppression on an electroencephalogram.

Step-by-Step Solution

1
Identify the clinical presentation and timing.
The patient is in continuous generalized tonic-clonic status epilepticus for 18 minutes.
Seizure duration greater than 5 minutes defines status epilepticus, necessitating immediate protocolized pharmacologic escalation.
2
Determine the first-line therapy (initial phase).
Intravenous lorazepam is the initial drug of choice.
Rapid-acting benzodiazepines are the most effective agents for rapidly terminating prolonged seizure activity.
3
Determine the second-line therapy (established phase).
Intravenous fosphenytoin is administered next.
To prevent recurrence or terminate ongoing seizures if benzodiazepines fail, a long-acting non-benzodiazepine antiseizure drug must be given.
4
Determine the third-line therapy (refractory phase).
Intravenous propofol infusion is initiated.
Seizures refractory to first- and second-line agents require general anesthesia and intubation.
5
Determine the final rescue therapy (super-refractory phase).
Intravenous pentobarbital coma is used.
When standard anesthetic infusions fail, barbiturate coma is induced to achieve electroencephalographic burst suppression.

Key Concept

The algorithmic escalation of pharmacotherapy in status epilepticus progresses sequentially from rapid-acting benzodiazepines to non-benzodiazepine antiseizure medications, continuous anesthetics, and finally barbiturate coma.
Question 1125Question →

Paramedics rush a 1919-year-old college sophomore into the trauma bay following a 911 call from his dormitory roommates. The roommates report that he complained of an excruciating headache and severe nausea earlier in the day before becoming increasingly lethargic. He has no significant past medical history, takes no medications, and his vaccination status is unknown. Upon arrival, the patient is unresponsive to verbal commands and only groans in response to sternal rub (Glasgow Coma Scale score of 88). A petechial rash is noted on his lower extremities.

Initial vital signs show a temperature of 39.6∘C39.6^\circ\text{C} (103.3∘F103.3^\circ\text{F}), heart rate of 138/min138\text{/min}, blood pressure of 82/48 mm Hg82/48\text{ mm Hg}, respiratory rate of 8/min8\text{/min} with shallow effort, and oxygen saturation of 88%88\% on room air.

Arrange the following clinical interventions in the most appropriate sequential order for this patient's initial stabilization and diagnostic workup.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Endotracheal intubation, 2) IV fluids and empiric antibiotics, 3) CT scan of the head, and 4) Lumbar puncture.
The correct sequence prioritizes life-saving stabilization (ABCs) before medical management of shock/infection, followed by safe diagnostic sequencing. The patient's GCS of 8 and respiratory failure mandate immediate endotracheal intubation. Next, severe sepsis and suspected meningococcal meningitis require immediate fluid resuscitation, blood cultures, and empiric antibiotics (e.g., ceftriaxone, vancomycin, dexamethasone). Only after systemic stabilization should definitive diagnostic testing proceed. Because the patient has altered mental status, a CT scan of the head must be performed to rule out mass effect before safely proceeding to a lumbar puncture.

Step-by-Step Solution

1
Assess the airway and breathing first in any critically ill patient.
The patient has a GCS of 8 and respiratory depression, indicating an inability to protect his airway.
Securing the airway via endotracheal intubation prevents aspiration and corrects life-threatening hypoxia.
2
Evaluate and treat hemodynamic instability and the underlying life-threatening infection.
Intravenous fluids, blood cultures, and empiric antibiotics (with dexamethasone) are administered.
The patient is in septic shock with suspected meningococcemia. Antibiotics must be given as early as possible and never delayed for imaging or procedures.
3
Determine the safety of performing a lumbar puncture.
A non-contrast CT of the head is ordered.
Altered mental status (GCS 8) is a classic indication for neuroimaging prior to a lumbar puncture to rule out mass effect and prevent brain herniation.
4
Perform definitive diagnostic testing.
A lumbar puncture is performed.
Once mass effect is ruled out by the CT scan, cerebrospinal fluid can be safely collected to identify the specific pathogen and tailor directed antibiotic therapy.

Key Concept

In patients with suspected bacterial meningitis and altered mental status, the correct management sequence is: 1) Secure ABCs (intubation if GCS ≤ 8), 2) Blood cultures and empiric antibiotics, 3) CT head, and 4) Lumbar puncture.
Estimated Time:1m 0s
Question 1126Question →

A 45-year-old woman is evaluated in the emergency department for severe, colicky right upper quadrant abdominal pain that radiates to her right scapula, accompanied by nausea. The pain began 6 hours ago after she ate a heavy meal. She is afebrile, and her vital signs are within normal limits. Physical examination reveals tenderness to palpation in the right upper quadrant without rebound or guarding. The Murphy sign is negative. Laboratory evaluation shows:

Total bilirubin: 2.1 mg/dL
Direct bilirubin: 1.5 mg/dL
Alkaline phosphatase: 250 U/L
Aspartate aminotransferase (AST): 110 U/L
Alanine aminotransferase (ALT): 125 U/L
Lipase: 45 U/L
Leukocyte count: 8,500/mm³

A right upper quadrant ultrasound demonstrates cholelithiasis without gallbladder wall thickening or pericholecystic fluid. The common bile duct measures 9 mm in diameter, but no stone is visualized within it. Which of the following is the most appropriate next step in the diagnostic workup of this patient?

Show answer & explanation

Answer: Magnetic resonance cholangiopancreatography

Answer

Magnetic resonance cholangiopancreatography is the most appropriate next step because the patient's presentation places her at intermediate risk for choledocholithiasis, requiring non-invasive confirmation.
The correct option is Magnetic resonance cholangiopancreatography (MRCP). The patient's presentation of biliary colic, a dilated common bile duct (CBD) of 9 mm, and elevated liver function tests suggests choledocholithiasis. However, because she does not have high-risk features (such as clinical ascending cholangitis, a directly visualized CBD stone on ultrasound, or a total bilirubin greater than 4.0 mg/dL), her risk is classified as intermediate (10-50%). For intermediate-risk patients, current guidelines recommend non-invasive evaluation of the biliary tree with MRCP or endoscopic ultrasound (EUS) to confirm the diagnosis before proceeding to invasive procedures.

Step-by-Step Solution

1
Evaluate the clinical, sonographic, and laboratory findings.
The patient has symptomatic cholelithiasis, a dilated common bile duct (9 mm), and mildly elevated liver function tests including bilirubin, but lacks ascending cholangitis or a bilirubin level over 4.0 mg/dL.
Accurate interpretation of these initial baseline investigations is necessary to stratify the patient's risk for a common bile duct stone.
2
Stratify the risk of choledocholithiasis according to established guidelines.
The combination of abnormal liver biochemistries and a dilated common bile duct (without high-risk predictors) categorizes the patient as having an intermediate probability (10% to 50%) of choledocholithiasis.
Risk stratification determines whether the patient should proceed directly to invasive therapeutic testing, non-invasive confirmatory imaging, or surgical intervention.
3
Select the guideline-indicated diagnostic test based on the risk category.
The correct test is a non-invasive confirmatory study, such as magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS).
This confirms the presence of a stone before subjecting an intermediate-risk patient to the procedural risks of an invasive procedure like ERCP.

Key Concept

Patients with an intermediate risk for choledocholithiasis (abnormal liver function tests and/or dilated common bile duct on ultrasound) should undergo non-invasive confirmatory testing with magnetic resonance cholangiopancreatography (MRCP) or endoscopic ultrasound (EUS) prior to invasive interventions.
Question 1127Question →

A 6868-year-old man presents to the clinic for follow-up of newly diagnosed atrial fibrillation. Three weeks ago, he presented to the emergency department with palpitations and was found to be in paroxysmal non-valvular atrial fibrillation. An echocardiogram demonstrated a structurally normal heart with a left ventricular ejection fraction of 60%60\%. He spontaneously converted to normal sinus rhythm and is currently asymptomatic. His past medical history is significant for hypertension, type 22 diabetes mellitus, and a seizure disorder secondary to a remote traumatic brain injury. His medications include lisinopril, metformin, and phenytoin. He has been seizure-free for the past 44 years on his current dose of phenytoin. Vital signs are within normal limits. Recent laboratory studies, including a basic metabolic panel and complete blood count, are unremarkable. Liver function tests reveal a mildly elevated total bilirubin of 1.41.4 mg/dL (normal: 0.10.1-1.21.2 mg/dL) with normal transaminases and alkaline phosphatase. His CHA 2_2 DS 2_2-VASc score is calculated to be 33. Which of the following is the most appropriate pharmacologic intervention for stroke prevention in this patient?

Show answer & explanation

Answer: Initiate warfarin therapy

Answer

The most appropriate pharmacologic intervention is to initiate warfarin therapy.
This patient requires oral anticoagulation for stroke prevention due to a CHA2DS2-VASc score of 3. However, he is well-controlled on phenytoin, a potent inducer of both the cytochrome P450 system (particularly CYP3A4) and P-glycoprotein (P-gp). Direct oral anticoagulants (DOACs) such as apixaban, rivaroxaban, and dabigatran are substrates for these metabolic and efflux pathways. Co-administration of DOACs with potent inducers results in drastically reduced plasma concentrations of the anticoagulant, placing the patient at high risk for ischemic stroke. Furthermore, because DOACs lack widely available, standardized laboratory assays for routine therapeutic monitoring, their dosages cannot be safely titrated to overcome the induction effect. In contrast, while warfarin metabolism is also affected by hepatic induction, its therapeutic biologic effect is directly measurable via the International Normalized Ratio (INR). Therefore, a clinician can safely initiate warfarin and empirically titrate the dosage upward until the target therapeutic INR (2.0 to 3.0) is achieved, ensuring adequate stroke prevention.

Step-by-Step Solution

1
Calculate the stroke risk and determine the indication for therapy.
The patient has a CHA2DS2-VASc score of 3, providing a strong indication for oral anticoagulation for stroke prevention.
Current clinical guidelines mandate oral anticoagulation for men with a score of 2 or higher.
2
Evaluate current medications for potential pharmacokinetic interactions.
The patient takes phenytoin, which is a potent inducer of hepatic cytochrome P450 enzymes (specifically CYP3A4) and the efflux transporter P-glycoprotein (P-gp).
Recognizing potent inducers or inhibitors is critical before prescribing new long-term pharmacotherapy.
3
Assess the metabolism and monitoring parameters of available oral anticoagulants.
Direct oral anticoagulants (DOACs) are substrates of CYP3A4 and P-gp, and lack standard laboratory tests for routine titration. Warfarin is metabolized hepatically but can be monitored via the INR.
DOACs will have unpredictably low and subtherapeutic plasma levels when given with phenytoin, increasing the risk of ischemic stroke.
4
Select the safest and most effective anticoagulant regimen.
Warfarin is selected because the dose can be empirically titrated up based on INR measurements to ensure therapeutic anticoagulation despite the presence of the enzyme inducer.
Direct monitoring of the biologic effect (INR) bypasses the pharmacokinetic unpredictability caused by the enzyme inducer.

Key Concept

Direct oral anticoagulants (DOACs) are contraindicated or strongly cautioned in patients taking potent CYP3A4 or P-glycoprotein inducers (such as phenytoin or carbamazepine) because induction significantly reduces DOAC levels and risks therapeutic failure. Warfarin is preferred because its dose can be empirically titrated using the International Normalized Ratio (INR).
Question 1128Question →

A 54-year-old man is evaluated in the intensive care unit for new-onset right lower extremity swelling and pain. He was admitted six days ago for an acute right-sided pulmonary embolism and was subsequently started on a continuous unfractionated heparin infusion. His initial recovery was uncomplicated. Today, physical examination reveals a swollen, erythematous, and tender right calf. His vital signs are temperature 37.1°C (98.8°F), blood pressure 128/82 mmHg, and heart rate 88/min.

Recent laboratory studies are as follows:

Laboratory TestResultReference Range
Hemoglobin13.2 g/dL13.5-17.5 g/dL (male)
Platelet count, today85,000/mm³150,000-400,000/mm³
Platelet count, admission260,000/mm³150,000-400,000/mm³
Serum creatinine1.0 mg/dL0.6-1.2 mg/dL

A lower extremity venous Doppler ultrasound confirms an acute occlusive deep vein thrombosis in the right popliteal vein. Which of the following is the most appropriate next step in the pharmacologic management of this patient?

Show answer & explanation

Answer: Discontinue unfractionated heparin and initiate an argatroban infusion

Answer

The most appropriate intervention is to discontinue the unfractionated heparin and initiate an argatroban infusion.
The clinical presentation is highly suggestive of Heparin-Induced Thrombocytopenia (HIT) Type 2. This condition is characterized by a platelet count drop of >50%, typically occurring 5-10 days after heparin initiation, and is paradoxically highly prothrombotic, often complicated by new events like a deep vein thrombosis. The standard of care requires the immediate cessation of all heparin products and the initiation of a non-heparin anticoagulant. Argatroban, a direct thrombin inhibitor, is an appropriate choice to provide immediate anticoagulation and prevent further thrombosis while the diagnosis is confirmed.

Step-by-Step Solution

1
Evaluate the patient's acute thrombocytopenia and new thrombosis in the context of recent medication exposure.
The timing (day 6 of therapy) and severity (>50% drop) of the thrombocytopenia, combined with a new thrombosis, yield a high 4T score strongly pointing to Heparin-Induced Thrombocytopenia (HIT) Type 2.
Calculating a 4T score is essential to estimate the pretest probability of HIT before taking interventional steps.
2
Determine the immediate pharmacologic intervention required for suspected HIT.
All heparin-containing products must be discontinued immediately without waiting for confirmatory laboratory testing.
Heparin-PF4 autoantibodies drive the pathogenesis, so removing the trigger is the critical first step in stabilization.
3
Select a safe alternative anticoagulant to treat the new deep vein thrombosis and underlying pulmonary embolism.
Initiate a non-heparin anticoagulant, such as a direct thrombin inhibitor (argatroban).
Patients with HIT are highly prothrombotic and require immediate alternative anticoagulation that does not cross-react with HIT autoantibodies.

Key Concept

Management of Heparin-Induced Thrombocytopenia (HIT)
Estimated Time:1m 30s
Question 1129Question →

A 58-year-old man is brought to the emergency department by emergency medical services due to severe, crushing substernal chest pain that began one hour ago while he was resting. The pain radiates to his left jaw and is associated with profound dizziness and diaphoresis. His medical history is significant for hypertension and type 2 diabetes mellitus. On arrival, he appears ashen and lethargic. Vital signs show a temperature of 36.6°C (97.9°F), blood pressure of 74/42 mmHg, heart rate of 112/min, respiratory rate of 20/min, and oxygen saturation of 95% on ambient air. Physical examination demonstrates prominent jugular venous distension, but pulmonary auscultation reveals clear lung fields bilaterally without crackles or wheezes. A rapid 12-lead electrocardiogram demonstrates 3-mm ST-segment elevations in leads II, III, and aVF, with reciprocal ST-segment depressions in leads I and aVL. Which of the following is the most appropriate initial step in the management of this patient?

Show answer & explanation

Answer: Administration of a rapid intravenous isotonic crystalloid bolus

Answer

The correct answer is the administration of a rapid intravenous isotonic crystalloid bolus to optimize right ventricular preload.
The patient's presentation of an inferior ST-elevation myocardial infarction (leads II, III, aVF) combined with profound hypotension, jugular venous distension, and clear lungs is highly specific for a right ventricular infarction. Because the ischemic right ventricle functions primarily as a passive conduit, it is highly dependent on adequate preload to push blood into the pulmonary circulation and subsequently fill the left ventricle. When profound hypotension is present, the immediate stabilizing intervention is to maximize right ventricular preload by administering a rapid intravenous isotonic crystalloid bolus.

Step-by-Step Solution

1
Analyze the clinical presentation and vital signs.
The patient is in cardiogenic shock (blood pressure 74/42 mmHg) with elevated jugular venous pressure but clear lung fields.
Identifying the triad of hypotension, elevated jugular venous pressure, and clear lungs is critical for diagnosing right ventricular failure.
2
Correlate the physical findings with the electrocardiogram results.
ST-segment elevations in inferior leads (II, III, aVF) suggest an inferior myocardial infarction, which involves the right ventricle in up to 50% of cases.
Inferior STEMIs are typically caused by right coronary artery occlusion, which also supplies the right ventricle.
3
Determine the physiological requirements for stabilization.
The ischemic right ventricle loses contractility and becomes highly dependent on venous return (preload) to pump blood to the left side of the heart.
Without adequate preload, left ventricular filling plummets, causing profound systemic hypotension.
4
Select the immediate intervention that addresses the hemodynamic instability.
Isotonic crystalloid boluses are required to increase right-sided filling pressures.
Hemodynamic stabilization (ABCs) must be initiated prior to confirmatory diagnostics (like a right-sided ECG) or definitive transfer (to the catheterization laboratory).

Key Concept

Patients with right ventricular myocardial infarction (inferior STEMI, clear lungs, hypotension, jugular venous distension) are highly preload-dependent; immediate stabilization requires intravenous crystalloid boluses to maintain cardiac output, and preload-reducing agents (nitrates, diuretics) must be avoided.
Question 1130Question →

A 62-year-old woman is evaluated in the ambulatory care clinic for a post-hospital discharge follow-up. Four days ago, she was discharged after a 3-day hospitalization for a non-ST-segment elevation myocardial infarction (NSTEMI). During her hospitalization, she underwent percutaneous coronary intervention with the placement of a drug-eluting stent in the right coronary artery. Her medical history is significant for type 2 diabetes mellitus, gastroesophageal reflux disease, and stage 4 chronic kidney disease.

Current medications include:
* Aspirin 81 mg daily
* Clopidogrel 75 mg daily
* Metoprolol succinate 50 mg daily
* Lisinopril 20 mg daily
* Atorvastatin 80 mg daily
* Metformin 1000 mg twice daily
* Omeprazole 40 mg daily

Laboratory studies obtained today show:

TestResult
Serum sodium138 mEq/L
Serum potassium4.6 mEq/L
Blood urea nitrogen34 mg/dL
Serum creatinine2.3 mg/dL (baseline 2.2 mg/dL)
Estimated glomerular filtration rate24 mL/min/1.73 m²
Hemoglobin A1c7.8%

Which of the following pharmacologic interventions are indicated for this patient at this time? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Discontinue metformin; Replace omeprazole with pantoprazole

Answer

The correct interventions are to discontinue metformin and replace omeprazole with pantoprazole.
This patient requires two immediate pharmacologic adjustments. First, metformin must be discontinued because her estimated glomerular filtration rate (eGFR) is less than 30 mL/min/1.73 m2, placing her at a high risk for metformin-associated lactic acidosis. Second, omeprazole should be replaced with an alternative acid-suppressing agent, such as pantoprazole or a histamine H2-receptor antagonist. Omeprazole is a strong inhibitor of the cytochrome P450 2C19 (CYP2C19) enzyme, which is required to convert clopidogrel into its active antiplatelet metabolite. Concurrent use of omeprazole and clopidogrel reduces the efficacy of clopidogrel and increases the risk of major adverse cardiovascular events, including stent thrombosis. Pantoprazole does not significantly inhibit CYP2C19 and is a safer alternative.

Step-by-Step Solution

1
Review the patient's renal function against her current medication list.
The patient has an eGFR of 24 mL/min/1.73 m2. Metformin is contraindicated below an eGFR of 30 mL/min/1.73 m2.
Continuing metformin in advanced renal failure poses an unacceptably high risk for life-threatening lactic acidosis.
2
Evaluate the patient's post-myocardial infarction regimen for severe drug-drug interactions.
The patient is taking omeprazole alongside clopidogrel.
Omeprazole is a strong CYP2C19 inhibitor, which prevents clopidogrel from converting to its active antiplatelet metabolite, thereby increasing the risk of stent thrombosis. A safer agent like pantoprazole must be substituted.
3
Assess the appropriateness of other cardiac medications in the context of chronic kidney disease.
Atorvastatin requires no renal adjustment. Lisinopril is safe to continue given stable baseline creatinine and normokalemia. Spironolactone is contraindicated due to the eGFR < 30 mL/min/1.73 m2.
Recognizing the indications and contraindications for secondary prevention medications ensures optimal cardiac remodeling without precipitating iatrogenic harm.

Key Concept

Medication reconciliation and pharmacologic adjustments in chronic kidney disease and post-acute coronary syndrome.
Estimated Time:1m 30s
Question 1131Question →

A 6262-year-old woman is evaluated in the ambulatory clinic for a routine follow-up. She has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of 30%30\%, type 2 diabetes mellitus, and osteoarthritis. She also reports a two-day history of dysuria and increased urinary frequency. Current medications include sacubitril-valsartan, metoprolol succinate, spironolactone, metformin, empagliflozin, and over-the-counter ibuprofen. Her blood pressure is 118/76118/76 mmHg and her pulse is 6868/min. Physical examination shows 1+1+ bilateral pitting edema of the lower extremities.

Laboratory studies from today show:
- Serum sodium: 137137 mEq/L
- Serum potassium: 5.35.3 mEq/L
- Serum creatinine: 2.32.3 mg/dL (Baseline 33 months ago: 1.41.4 mg/dL)
- Estimated GFR: 2424 mL/min/1.731.73 m 2^2
- Urinalysis: Positive for leukocyte esterase and nitrites, >50>50 WBCs/hpf

Which of the following pharmacologic interventions are appropriate for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Advise discontinuation of over-the-counter ibuprofen; Discontinue metformin therapy; Discontinue spironolactone therapy

Answer

The correct interventions are to advise the discontinuation of ibuprofen, discontinue metformin, and discontinue spironolactone.
The correct interventions involve discontinuing medications that are now toxic due to the patient's acute kidney injury and hyperkalemia. Ibuprofen must be stopped because NSAIDs cause afferent arteriolar vasoconstriction, worsening GFR and fluid retention. Metformin must be discontinued because its clearance is significantly reduced at an eGFR of <30<30 mL/min/1.731.73 m 2^2, leading to a high risk of lactic acidosis. Spironolactone must be discontinued because mineralocorticoid receptor antagonists are contraindicated in patients with an eGFR <30<30 mL/min/1.731.73 m 2^2 or a serum potassium >5.0>5.0 mEq/L.

Step-by-Step Solution

1
Analyze the patient's current clinical status and laboratory findings.
The patient has developed an acute kidney injury (creatinine increased from 1.41.4 to 2.32.3 mg/dL, eGFR dropped to 2424 mL/min/1.731.73 m 2^2) along with hyperkalemia (K +^+ 5.35.3 mEq/L) and fluid overload.
Identifying the acute physiological derangements is necessary to guide medication reconciliation.
2
Evaluate current home medications against the new laboratory parameters.
Ibuprofen is nephrotoxic and exacerbates heart failure. Metformin is contraindicated at eGFR <30<30. Spironolactone is contraindicated with eGFR <30<30 and potassium >5.0>5.0.
Preventing adverse drug events requires stopping medications that become unsafe during acute organ dysfunction.
3
Assess the proposed new interventions for safety and efficacy.
Increasing ARNI dosing is unsafe due to AKI/hyperkalemia. Pioglitazone is contraindicated in heart failure. Trimethoprim-sulfamethoxazole for the UTI is unsafe due to severe hyperkalemia risk.
New prescriptions must not worsen the patient's existing acute metabolic or hemodynamic derangements.

Key Concept

Comprehensive medication reconciliation in the setting of acute kidney injury and hyperkalemia requires discontinuing nephrotoxic agents (NSAIDs), holding medications contraindicated at low GFR thresholds (metformin), and avoiding drugs that exacerbate hyperkalemia (spironolactone, trimethoprim).
Estimated Time:2m 0s
Question 1132Question →

A 75-year-old woman is brought to the outpatient clinic by her daughter for evaluation of bothersome urinary symptoms. Over the past three months, the patient has experienced sudden, overwhelming urges to urinate, often resulting in urinary leakage before she can reach the bathroom. She currently voids approximately 10 to 12 times a day. Her medical history is significant for Alzheimer dementia, for which she is prescribed donepezil, and essential hypertension, which is well-controlled with amlodipine. Vital signs are within normal limits. Physical examination, including a pelvic exam, is unremarkable. A bladder ultrasound reveals a post-void residual volume of 35 mL. Urinalysis shows no signs of infection. Behavioral interventions, including scheduled voiding and fluid management, were initiated four weeks ago but have been unsuccessful. Which of the following is the most appropriate medication to initiate for this patient's urinary symptoms?

Show answer & explanation

Answer: Mirabegron

Answer

Mirabegron
The correct answer is mirabegron. This patient presents with overactive bladder (OAB) characterized by urge incontinence, urinary frequency, and urgency. Because behavioral interventions have failed, pharmacotherapy is indicated. The standard initial pharmacotherapies for OAB include antimuscarinic agents and beta-3 adrenergic agonists. However, this patient has Alzheimer dementia and is being treated with donepezil, an acetylcholinesterase inhibitor. Antimuscarinic drugs (especially those that cross the blood-brain barrier) can cause profound cognitive impairment in the elderly and directly antagonize the beneficial effects of acetylcholinesterase inhibitors. Mirabegron is a beta-3 adrenergic agonist that causes relaxation of the detrusor muscle during the urine storage phase. It effectively increases bladder capacity and reduces OAB symptoms without exerting any anticholinergic effects, making it the safest and most appropriate choice for this patient.

Step-by-Step Solution

1
Identify the patient's primary clinical problem and active comorbidities.
The patient has overactive bladder (OAB) manifesting as urge incontinence, alongside a critical comorbidity of Alzheimer dementia currently treated with donepezil.
Choosing a pharmacologic intervention for OAB requires careful avoidance of drugs that could worsen the patient's underlying neurological condition or interact with her current medications.
2
Determine the standard pharmacological classes available for overactive bladder.
The two primary classes are antimuscarinic agents (e.g., oxybutynin, solifenacin) and beta-3 adrenergic agonists (e.g., mirabegron).
Since conservative behavioral management has failed, pharmacotherapy is the next step in the treatment algorithm.
3
Evaluate the safety and interaction profiles of the available classes in the context of dementia.
Antimuscarinic agents block acetylcholine receptors, which can directly cause cognitive impairment and pharmacodynamically antagonize acetylcholinesterase inhibitors like donepezil.
Medications with central anticholinergic properties must be rigorously avoided in the elderly, particularly those with established cognitive decline.
4
Select the optimal medication based on efficacy and safety.
Mirabegron is selected as the most appropriate agent.
Mirabegron stimulates beta-3 receptors in the bladder to promote detrusor relaxation during the storage phase without interfering with cholinergic transmission in the central nervous system.

Key Concept

Pharmacologic management of overactive bladder in patients with dementia
Question 1133Question →

A 71-year-old man is evaluated in the clinic for a routine follow-up. He has a history of nonvalvular atrial fibrillation, hypertension, and an ischemic stroke three years ago. His daily medications include apixaban, metoprolol succinate, and lisinopril. Four weeks ago, the patient had a focal-onset seizure with impaired awareness that generalized. He was evaluated in the emergency department, diagnosed with post-stroke epilepsy, and started on carbamazepine. He has not had any recurrent seizures and reports no adverse effects. Vital signs and physical examination are unremarkable. Recent laboratory studies show a normal complete blood count, a normal comprehensive metabolic panel, and a therapeutic carbamazepine level of 8 mcg/mL (therapeutic range: 4-12 mcg/mL). Which of the following is the most appropriate modification to this patient's stroke prophylaxis regimen?

Show answer & explanation

Answer: Discontinue apixaban and initiate warfarin therapy

Answer

Discontinue apixaban and initiate warfarin therapy
The correct intervention is to discontinue apixaban and initiate warfarin therapy. Apixaban is heavily metabolized by the cytochrome P450 3A4 (CYP3A4) pathway and is a major substrate for the P-glycoprotein (P-gp) efflux transporter in the gastrointestinal tract. Carbamazepine is a potent inducer of both CYP3A4 and P-gp. Concurrent administration of carbamazepine significantly increases the metabolism and efflux of apixaban, reducing its systemic concentration by 50% or more. This subtherapeutic anticoagulation places a patient with atrial fibrillation and a prior stroke at an unacceptably high risk for recurrent thromboembolic events. Because all direct oral anticoagulants (DOACs) are P-gp substrates and most are CYP3A4 substrates, they are generally contraindicated in patients taking strong dual inducers (e.g., carbamazepine, phenytoin, rifampin). Warfarin is the most appropriate alternative. Although warfarin metabolism (via CYP2C9, 1A2, and 3A4) is also induced by carbamazepine, its anticoagulant effect can be directly measured and safely titrated using the International Normalized Ratio (INR), ensuring the patient remains therapeutically anticoagulated.

Step-by-Step Solution

1
Identify the primary clinical problem.
The patient is taking apixaban for stroke prophylaxis in atrial fibrillation and was recently started on carbamazepine for post-stroke epilepsy.
Recognizing the concomitant use of these medications is essential to evaluate for potential drug-drug interactions.
2
Analyze the pharmacokinetic properties of the medications.
Apixaban is a substrate for both CYP3A4 and P-glycoprotein (P-gp). Carbamazepine is a strong inducer of both CYP3A4 and P-gp.
Understanding the metabolism and transport of DOACs predicts how their serum levels will be affected by inducers.
3
Determine the clinical consequence of the interaction.
Carbamazepine will significantly decrease systemic apixaban concentrations, placing the patient at a high risk for recurrent ischemic stroke.
Subtherapeutic anticoagulation in a patient with a prior stroke and atrial fibrillation carries a high morbidity risk.
4
Select the most appropriate alternative therapy.
Warfarin should be initiated because, unlike DOACs, its anticoagulant effect can be directly measured and titrated using the INR.
While warfarin is also subject to enzyme induction, its monitorability allows for safe dose adjustments to maintain a therapeutic effect.

Key Concept

Direct oral anticoagulants (DOACs) like apixaban are substrates for CYP3A4 and P-glycoprotein (P-gp); concomitant use with strong dual inducers like carbamazepine is contraindicated due to subtherapeutic drug levels and requires switching to warfarin, which can be monitored via INR.
Question 1134Question →

A 28-year-old woman is brought to the emergency department with severe agitation, palpitations, and confusion. She has a history of Graves disease but has not taken her antithyroid medications for the past three months. Her temperature is 39.8°C (103.6°F), blood pressure is 150/70 mmHg, and heart rate is 145/min and irregular. Physical examination reveals diaphoresis, a fine resting tremor, and a diffusely enlarged, non-tender thyroid gland with a prominent bruit. An electrocardiogram shows atrial fibrillation with a rapid ventricular response. A clinical diagnosis of thyroid storm is established.

Arrange the following pharmacologic interventions in the most appropriate chronological order of administration for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first administer intravenous propranolol, followed by oral propylthiouracil, then oral potassium iodide, and finally refer for radioactive iodine ablation after stabilization.
The correct pharmacological sequence for thyroid storm prioritizes life-saving hemodynamic control with beta-blockers, followed by cessation of hormone synthesis using thionamides, followed by cessation of hormone release using iodine, and eventually concludes with long-term definitive therapy once the acute episode has resolved.

Step-by-Step Solution

1
Stabilize hemodynamics and control adrenergic symptoms.
Intravenous propranolol is administered.
Immediate beta-blockade is required to reduce the life-threatening extreme tachycardia and autonomic hyperactivity, while also partially blocking peripheral conversion of T4 to T3.
2
Block new thyroid hormone synthesis.
Oral propylthiouracil (PTU) is administered.
Before the thyroid gland is exposed to high doses of iodine (which would fuel further synthesis), the cellular machinery for synthesizing new hormone must be shut down.
3
Block the release of preformed thyroid hormone.
Oral potassium iodide is administered at least 1 hour after PTU.
The sudden iodine load rapidly inhibits the proteolytic release of T3 and T4 from thyroglobulin (Wolff-Chaikoff effect), rapidly lowering serum hormone levels.
4
Provide long-term definitive therapy.
The patient is referred for radioactive iodine ablation.
Once the acute crisis is fully resolved and the patient returns to a euthyroid state, definitive therapy is planned to prevent future recurrences.

Key Concept

The sequential pharmacologic management of thyroid storm dictates that autonomic control is established first, and thionamides must be given prior to iodine to prevent substrate loading and subsequent exacerbation of thyrotoxicosis.
Question 1135Question →

Match each clinical presentation of a patient with suspected pulmonary embolism (PE) to the most appropriate next step in the diagnostic workup sequence.

Click a left item, then click its matching right item

Items

A 65-year-old female, 3 days post-total knee arthroplasty, presents with sudden-onset dyspnea. Blood pressure is 112/72 mmHg, heart rate is 125/min, and estimated glomerular filtration rate (eGFR) is 75 mL/min/1.73 m².
A 52-year-old male presents with sudden pleuritic chest pain and confusion. Blood pressure is 70/40 mmHg, heart rate is 145/min, and oxygen saturation is 82% on a non-rebreather mask. He is deemed too unstable for transport.
A 71-year-old male presents with acute shortness of breath and a heart rate of 115/min. His baseline chest radiograph is normal, but his laboratory workup reveals an eGFR of 22 mL/min/1.73 m².
A 24-year-old healthy female presents with sudden chest pain after a 6-hour flight. Vital signs are normal except for a heart rate of 105/min. Her calculated modified Wells score is 1.5 (intermediate probability).

Matches

Show answer & explanation

Answer

High probability and stable -> CTPA; High probability, unstable for transport -> Bedside echocardiography; High probability with severe renal impairment -> V/Q scan; Intermediate probability -> D-dimer assay.
Test sequencing for suspected pulmonary embolism is dictated by three primary factors: pretest clinical probability, hemodynamic stability, and contraindications to contrast media. Hemodynamically stable patients with a high pretest probability require prompt definitive imaging with CTPA. If CTPA is contraindicated (e.g., severe renal impairment), a V/Q scan is the preferred alternative provided the baseline chest radiograph is clear. For hemodynamically unstable patients who cannot safely be transported, bedside echocardiography is utilized to identify acute right ventricular strain. In patients with low or intermediate pretest probability, a D-dimer assay is the appropriate initial step to rule out the diagnosis, preventing unnecessary radiation exposure.

Step-by-Step Solution

1
Assess pretest probability and hemodynamic stability for each patient.
Patients 1, 2, and 3 have high pretest probabilities, while Patient 4 has an intermediate probability. Patient 2 is the only hemodynamically unstable patient.
Diagnostic sequencing for pulmonary embolism is strictly algorithmic, beginning with risk stratification (e.g., Wells criteria) and hemodynamic status.
2
Evaluate contraindications for standard imaging (CTPA) in the high-probability cohort.
Patient 1 has normal renal function and can undergo CTPA. Patient 3 has severe renal impairment, requiring an alternative modality.
Intravenous iodinated contrast used in CTPA poses a severe risk of contrast-induced nephropathy in patients with an eGFR below 30 mL/min/1.73 m².
3
Select the appropriate diagnostic tests based on constraints.
Patient 1 receives CTPA. Patient 2 receives bedside echocardiography due to transport risks. Patient 3 receives a V/Q scan to protect renal function. Patient 4 receives a D-dimer test to potentially rule out PE.
This matches guideline-indicated test sequencing for acute pulmonary embolism, maximizing diagnostic yield while minimizing patient harm.

Key Concept

Diagnostic algorithm and test sequencing for acute pulmonary embolism based on hemodynamic stability, pretest probability, and absolute contraindications.
Question 1136Question →

A 5555-year-old male establishes care for hypertension management. His medical history is significant for bipolar I disorder and mild persistent asthma. His bipolar disorder has been well-controlled on lithium carbonate for the past eight years without recurrent mood episodes. His asthma is managed with an as-needed albuterol inhaler. Blood pressure readings from his past three clinic visits have consistently averaged 154/96154/96 mmHg, despite strict adherence to a low-sodium diet and a daily exercise regimen. Today, his blood pressure is 156/94156/94 mmHg, and his pulse is 7272/min. Physical examination reveals clear lungs bilaterally with no wheezing. Laboratory studies show a serum creatinine of 0.90.9 mg/dL, serum potassium of 4.24.2 mEq/L, and a serum lithium level of 0.80.8 mEq/L (therapeutic range: 0.60.6 to 1.21.2 mEq/L). The physician decides to initiate pharmacologic therapy for his hypertension. Which of the following is the most appropriate medication to prescribe for this patient?

Show answer & explanation

Answer: Amlodipine

Answer

The correct answer is amlodipine, as it does not interact with lithium or exacerbate asthma.
The correct answer is amlodipine. This patient requires pharmacotherapy for newly diagnosed hypertension. He has two critical comorbidities to consider: bipolar disorder managed with lithium, and asthma. Lithium has a very narrow therapeutic index. Its clearance is exclusively renal and closely tied to sodium handling. Amlodipine is a dihydropyridine calcium channel blocker that effectively reduces blood pressure without clinically significant effects on renal lithium clearance. Furthermore, it does not act on beta-adrenergic receptors and is entirely safe for patients with asthma.

Step-by-Step Solution

1
Evaluate the patient's comorbidities and current medication list.
The patient requires antihypertensive therapy and concurrently has asthma (uses albuterol) and bipolar disorder (takes lithium).
Identifying existing conditions and medications is critical to prevent adverse drug events and dangerous drug-drug interactions when initiating new pharmacotherapy.
2
Identify contraindications and drug interactions for common antihypertensive classes.
Non-selective beta-blockers are contraindicated in asthma. Thiazide diuretics, ACE inhibitors, and ARBs significantly decrease renal lithium clearance.
Lithium has a narrow therapeutic index, and its renal excretion is highly dependent on sodium and fluid balance. Medications that alter proximal tubular sodium handling or glomerular filtration can quickly lead to lithium toxicity.
3
Select the safest antihypertensive agent that avoids these risks.
Amlodipine, a calcium channel blocker, is selected.
Calcium channel blockers do not significantly impact lithium levels and are safe for patients with reactive airway disease.

Key Concept

When treating hypertension in a patient taking lithium, thiazide diuretics, ACE inhibitors, and ARBs should generally be avoided because they decrease renal lithium clearance and increase the risk of toxicity. Calcium channel blockers are safe and preferred.
Question 1137Question →

A 58-year-old man presents to the primary care clinic reporting a four-week history of progressively worsening shortness of breath, particularly when climbing stairs. He also notes waking up gasping for air at night and increased swelling in his ankles. He has a history of type 2 diabetes mellitus and hypertension. His current medications include metformin and lisinopril. Vital signs show a blood pressure of 145/90 mm Hg, heart rate of 92/min, and respiratory rate of 18/min. Physical examination reveals elevated jugular venous pressure, a regular rhythm with an S3 gallop, bibasilar lung crackles, and 2+ bilateral pitting edema to the mid-calves. The physician suspects new-onset heart failure. Which of the following diagnostic tests should be ordered concurrently as part of the initial baseline evaluation for this patient? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: Transthoracic echocardiography; 12-lead electrocardiogram; Serum thyroid-stimulating hormone level

Answer

The initial baseline evaluation for new-onset heart failure should concurrently include transthoracic echocardiography, a 12-lead electrocardiogram, and a serum thyroid-stimulating hormone level.
The patient presents with classic signs and symptoms of new-onset decompensated heart failure. According to clinical guidelines, the initial diagnostic sequence must establish the diagnosis, assess cardiac structure and function, and identify potential precipitating or reversible causes. A 12-lead electrocardiogram is essential to evaluate for arrhythmias, conduction delays, or evidence of prior myocardial infarction. Transthoracic echocardiography is the primary non-invasive imaging modality required to determine the left ventricular ejection fraction, assess valvular function, and categorize the heart failure type. Additionally, checking a serum thyroid-stimulating hormone level is routinely indicated because both hyperthyroidism and hypothyroidism can precipitate or exacerbate heart failure, representing a critical reversible etiology.

Step-by-Step Solution

1
Identify the primary clinical syndrome.
The patient's symptoms (dyspnea on exertion, orthopnea) and signs (JVP, S3 gallop, crackles, edema) strongly indicate new-onset decompensated heart failure.
Recognizing the syndrome dictates the guideline-directed initial diagnostic workup.
2
Determine the necessary baseline non-invasive cardiac tests.
Select a 12-lead electrocardiogram to check electrical activity and transthoracic echocardiography to assess structural function and ejection fraction.
These are the gold standard preliminary tests required to phenotype the heart failure (reduced vs. preserved ejection fraction) and guide therapy.
3
Identify required concurrent baseline laboratory studies.
Select serum thyroid-stimulating hormone (TSH) level alongside standard blood work (CBC, CMP, BNP).
Thyroid dysfunction is a classic, potentially reversible cause or exacerbator of heart failure that must be ruled out initially.
4
Exclude premature or advanced diagnostic tests.
Rule out coronary angiography and cardiac magnetic resonance imaging.
These tests are indicated only after initial non-invasive workup raises specific suspicions (e.g., severe ischemia, infiltrative cardiomyopathy) or if initial testing is equivocal.

Key Concept

The initial diagnostic workup for new-onset heart failure includes concurrent functional assessment (ECG), structural imaging (echocardiography), and screening for reversible systemic causes (TSH).
Question 1138Question →

A 54-year-old man is brought to the emergency department after vomiting a large amount of bright red blood. He has a history of alcohol use disorder and decompensated cirrhosis complicated by ascites. Upon arrival, he appears confused and lethargic. His temperature is 36.8°C (98.2°F), pulse is 122/min, respirations are 22/min, and blood pressure is 86/50 mmHg. Oxygen saturation is 96% on room air. Physical examination reveals scleral icterus, spider angiomas, and a distended, non-tender abdomen with shifting dullness. Two large-bore intravenous lines are placed, and rapid fluid resuscitation with crystalloids and packed red blood cells is initiated. The patient is being prepared for an emergent upper endoscopy. Which of the following pharmacologic interventions should be administered immediately? (Select all that apply.)

Select all that apply

Show answer & explanation

Answer: Intravenous ceftriaxone; Intravenous octreotide

Answer

The correct interventions are intravenous ceftriaxone and intravenous octreotide.
The correct interventions are intravenous ceftriaxone and intravenous octreotide. In patients with cirrhosis who present with acute upper gastrointestinal bleeding, there is a very high likelihood of variceal hemorrhage. Medical management must be initiated concurrently with fluid and blood product resuscitation, even prior to diagnostic endoscopy. Intravenous octreotide, a somatostatin analog, is required to induce splanchnic vasoconstriction, which decreases portal venous inflow and lowers variceal pressure. Intravenous ceftriaxone is equally critical as antibiotic prophylaxis; cirrhotic patients with GI bleeding are at an exceedingly high risk for severe bacterial infections (like spontaneous bacterial peritonitis), and administering antibiotics significantly decreases the rate of infection, rebleeding, and overall mortality.

Step-by-Step Solution

1
Assess the patient's hemodynamic status and clinical presentation.
The patient is in hemorrhagic shock (tachycardia, hypotension) due to an acute upper gastrointestinal bleed, highly suspicious for variceal hemorrhage given the history of decompensated cirrhosis.
Identifying the etiology and severity of the bleed dictates the immediate resuscitation and pharmacologic priorities.
2
Identify the immediate pharmacologic therapies required before definitive endoscopic management.
The patient requires splanchnic vasoconstriction to reduce portal pressure and prophylactic antibiotics to prevent infectious complications.
Endoscopy is the definitive treatment, but temporizing medical therapies significantly improve mortality and procedural success.
3
Select the appropriate specific agents.
Intravenous octreotide provides splanchnic vasoconstriction, and intravenous ceftriaxone provides the necessary broad-spectrum antibiotic prophylaxis.
These two agents are the standard-of-care empirical interventions for cirrhotic patients presenting with suspected variceal hemorrhage.

Key Concept

Immediate pharmacologic management of suspected variceal hemorrhage in a cirrhotic patient requires a combination of splanchnic vasoconstrictors (e.g., intravenous octreotide) to reduce portal pressure and prophylactic antibiotics (e.g., intravenous ceftriaxone) to prevent infections and rebleeding.
Question 1139Question →

A 22-year-old male is brought to the emergency department after diving headfirst into a shallow lake. He is conscious but in severe respiratory distress, using accessory muscles to breathe. He reports an inability to feel or move his arms or legs. Vital signs include a temperature of 36.5°C (97.7°F), heart rate of 52/min, blood pressure of 80/40 mmHg, respiratory rate of 34/min with shallow effort, and oxygen saturation of 85% on room air. Physical examination demonstrates prominent diaphragmatic breathing, flaccid paralysis of all four extremities, and absent deep tendon reflexes.

Arrange the following steps in the most appropriate sequential order for the initial stabilization and diagnostic workup of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence prioritizes the primary trauma survey (Airway, Breathing, Circulation) followed by resuscitation adjuncts and finally definitive diagnostic imaging.
The initial stabilization of any trauma patient strictly follows the standard primary survey protocol. In a patient with a high cervical spine injury causing respiratory failure (hypoxemia, tachypnea, diaphragmatic breathing) and neurogenic shock (hypotension, bradycardia, flaccid paralysis), the absolute first priority is securing the airway while maintaining in-line cervical stabilization. Once the airway is protected and oxygenation is established, the next immediate step is to support circulation with intravenous fluids and vasopressors to maintain adequate spinal cord perfusion. Only after the airway and circulation are stabilized should resuscitation adjuncts, such as a portable chest radiograph to confirm tube placement, be performed. Definitive imaging, such as a CT scan of the cervical spine, is the final step in this sequence, as the patient must be stable enough to safely leave the resuscitation bay.

Step-by-Step Solution

1
Assess and secure the airway with cervical spine precautions.
Endotracheal intubation is performed.
The patient has impending respiratory failure and hypoxemia from loss of intercostal muscle innervation due to a high cervical cord injury.
2
Support circulation.
Intravenous fluids and vasopressors are administered.
The patient exhibits neurogenic shock (hypotension with paradoxical bradycardia) requiring immediate hemodynamic support.
3
Perform resuscitation adjuncts.
A portable chest radiograph is obtained.
This confirms the correct placement of the endotracheal tube and screens for immediate life-threatening chest pathology.
4
Proceed to definitive diagnostic imaging.
The patient is transported for a CT of the cervical spine.
The patient is now hemodynamically stable and has a protected airway, making transport to the radiology suite safe.

Key Concept

In trauma and suspected spinal cord injury, initial management strictly follows the primary survey, ensuring the airway is secured with cervical spine precautions before addressing circulation or pursuing definitive diagnostic imaging.
Question 1140Question →

A 42-year-old woman is referred to the endocrinology clinic due to treatment-resistant hypertension. She currently takes amlodipine, lisinopril, and hydrochlorothiazide at maximal tolerated doses, but her home blood pressure readings consistently range from 160/95 to 175/105 mmHg. Over the past year, she has also experienced episodic, severe, throbbing headaches accompanied by palpitations and profuse sweating. Her vital signs today show a blood pressure of 168/102 mmHg and a heart rate of 105/min. Physical examination is unremarkable, with no abdominal bruits or striae. Because of her classic symptoms, measurement of plasma free metanephrines is performed, revealing levels that are more than four times the upper limit of normal. Which of the following is the most appropriate next step in this patient's diagnostic workup?

Show answer & explanation

Answer: Computed tomography of the abdomen and pelvis

Answer

Computed tomography of the abdomen and pelvis
The correct sequence for diagnosing a pheochromocytoma involves establishing clinical suspicion, obtaining biochemical confirmation, and then performing anatomical localization. This patient has definitively positive biochemical testing (plasma free metanephrines >4 times normal). The next required step is to locate the tumor anatomically. Because approximately 90% of pheochromocytomas arise in the adrenal medulla and most extra-adrenal paragangliomas occur in the abdomen or pelvis, a computed tomography (CT) or magnetic resonance imaging (MRI) scan of the abdomen and pelvis is the most appropriate initial localizing study.

Step-by-Step Solution

1
Analyze the patient's clinical presentation.
The patient has treatment-resistant hypertension combined with the classic triad of episodic headaches, sweating, and palpitations, which is highly suspicious for a pheochromocytoma.
Identifying the clinical syndrome guides the biochemical evaluation.
2
Evaluate the results of the initial diagnostic testing.
Plasma free metanephrines are greater than four times the upper limit of normal, providing definitive biochemical confirmation of a catecholamine-secreting tumor.
The diagnostic pathway for endocrine tumors requires biochemical proof of hormone excess before attempting to locate the source.
3
Determine the appropriate sequential step in the workup.
Because the biochemical diagnosis is secure, the next step is anatomical localization using computed tomography (CT) or magnetic resonance imaging (MRI) of the abdomen and pelvis.
Approximately 90% of pheochromocytomas are located in the adrenal glands, and almost all others are intra-abdominal. Cross-sectional imaging is the most sensitive initial localizing test.

Key Concept

In the evaluation of suspected pheochromocytoma, definitive biochemical confirmation (via metanephrines) must be followed immediately by anatomical localization using cross-sectional imaging (CT or MRI) of the abdomen and pelvis.
PreviousPage 57 / 104Next
Patient Management Practice Questions — USMLE Step 3 — Page 57 | Examkin